← Leaderboards
Karl D Wittrup
Massachusetts Institute Of Technology
$33,463,127
Attributed
$35,505,470
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,505,470 · 8
By mechanism
R01$21,110,776 · 7
T32$14,394,694 · 1
Top collaborators
- Timothy M Fan4 shared
- Darrell J Irvine4 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Tyler E Jacks$53,083,831
Others in their field
Top investigators on “Protein Engineering”
- Gregory D Peterson · University Of Tennessee Knoxville$100,231,290
- Ernest Fontes · Cornell University$53,099,382
- D Gary Gilliland · Dana-Farber Cancer Institute$49,274,424
- Joel D Brock · Cornell University$47,673,738
- Jay D Keasling · University Of California-Berkeley$45,470,430
- David Rubin · Cornell University$39,936,738
Research focus
Protein EngineeringTumorDesignCellsAntibodiesResearch PersonnelAffinityEngineeringBaseProteinsMalignant NeoplasmsImmunoglobulin GDoseTherapeutic IndexAntigensSignal TransductionResponseKineticsMutantLigandsMediatingSurfaceAntibody EngineeringDiffusion
Grant awards (62)
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models$511,429
R01 · FY2025 · CA · contact PI
Localized immunotherapy using alum-binding therapeutics$505,710
R01 · FY2024 · EB
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models$484,753
R01 · FY2024 · CA · contact PI
Localized immunotherapy using alum-binding therapeutics$518,397
R01 · FY2023 · EB
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models$498,957
R01 · FY2023 · CA · contact PI
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models$521,821
R01 · FY2022 · CA · contact PI
Localized immunotherapy using alum-binding therapeutics$520,695
R01 · FY2022 · EB
Localized immunotherapy using alum-binding therapeutics$522,925
R01 · FY2021 · EB
Interdepartmental Biotechnology Training Program$481,930
T32 · FY2018 · GM · contact PI
Interdepartmental Biotechnology Training Program$885,619
T32 · FY2017 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$578,258
R01 · FY2017 · CA · contact PI
Localizing Immunotherapy to Improve Therapeutic Index$395,388
R01 · FY2017 · CA · contact PI
Interdepartmental Biotechnology Training Program$876,016
T32 · FY2016 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$578,258
R01 · FY2016 · CA · contact PI
Localizing Immunotherapy to Improve Therapeutic Index$395,388
R01 · FY2016 · CA · contact PI
Interdepartmental Biotechnology Training Program$866,658
T32 · FY2015 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$578,166
R01 · FY2015 · CA · contact PI
Localizing Immunotherapy to Improve Therapeutic Index$395,388
R01 · FY2015 · CA · contact PI
Interdepartmental Biotechnology Training Program$857,548
T32 · FY2014 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$560,553
R01 · FY2014 · CA · contact PI
Localizing Immunotherapy to Improve Therapeutic Index$385,527
R01 · FY2014 · CA · contact PI
Foundations of Pretargeted Radioimmunotherapy$285,065
R01 · FY2014 · CA · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$591,706
R01 · FY2013 · CA · contact PI
Interdepartmental Biotechnology Training Program$568,125
T32 · FY2013 · GM · contact PI
Localizing Immunotherapy to Improve Therapeutic Index$395,388
R01 · FY2013 · CA · contact PI
Foundations of Pretargeted Radioimmunotherapy$276,249
R01 · FY2013 · CA · contact PI
Interdepartmental Biotechnology Training Program$848,437
T32 · FY2012 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$561,219
R01 · FY2012 · CA · contact PI
Foundations of Pretargeted Radioimmunotherapy$293,882
R01 · FY2012 · CA · contact PI
Interdepartmental Biotechnology Training Program$839,572
T32 · FY2011 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$581,866
R01 · FY2011 · CA · contact PI
Foundations of Pretargeted Radioimmunotherapy$293,882
R01 · FY2011 · CA · contact PI
Interdepartmental Biotechnology Training Program$830,954
T32 · FY2010 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$621,974
R01 · FY2010 · CA · contact PI
Foundations of Pretargeted Radioimmunotherapy$319,869
R01 · FY2010 · CA · contact PI
Interdepartmental Biotechnology Training Program$826,768
T32 · FY2009 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$636,053
R01 · FY2009 · CA · contact PI
Foundations of Pretargeted Radioimmunotherapy$171,140
R01 · FY2009 · CA · contact PI
Interdepartmental Biotechnology Training Program$694,162
T32 · FY2008 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$671,000
R01 · FY2008 · CA · contact PI
Engineering and Analysis of T cell CD3 and IL2R Signals$575,774
R01 · FY2008 · AI · contact PI
Foundations of Pretargeted Radioimmunotherapy$250,134
R01 · FY2008 · CA · contact PI
Interdepartmental Biotechnology Training Program$897,517
T32 · FY2007 · GM · contact PI
Engineering and Analysis of T cell CD3 and IL2R Signals$579,644
R01 · FY2007 · AI · contact PI
Foundations of Pretargeted Radioimmunotherapy$251,771
R01 · FY2007 · CA · contact PI
Interdepartmental Biotechnology Training Program$936,676
T32 · FY2006 · GM · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$767,156
R01 · FY2006 · CA · contact PI
Engineering and Analysis of T cell CD3 and IL2R Signals$568,907
R01 · FY2006 · AI · contact PI
Foundations of Pretargeted Radioimmunotherapy$259,034
R01 · FY2006 · CA · contact PI
Engineered Antibody EGFR Antagonist Cancer Therapeutics$766,145
R01 · FY2005 · CA
Interdepartmental Biotechnology Training Program$762,836
T32 · FY2005 · GM
Engineering and Analysis of T cell CD3 and IL2R Signals$517,512
R01 · FY2005 · AI
Foundations of Pretargeted Radioimmunotherapy$281,459
R01 · FY2005 · CA
Interdepartmental Biotechnology Training Program$985,975
T32 · FY2004 · GM
Engineered Antibody EGFR Antagonist Cancer Therapeutics$747,137
R01 · FY2004 · CA
INTERDEPARTMENTAL BIOTECHNOLOGY PROGRAM$916,969
T32 · FY2003 · GM
Engineered Antibody EGFR Antagonist Cancer Therapeutics$728,775
R01 · FY2003 · CA
INTERDEPARTMENTAL BIOTECHNOLOGY PROGRAM$877,830
T32 · FY2002 · GM
Engineered Antibody EGFR Antagonist Cancer Therapeutics$780,000
R01 · FY2002 · CA
INTERDEPARTMENTAL BIOTECHNOLOGY PROGRAM$441,102
T32 · FY2001 · GM
PROTEIN QUALITY CONTROL IN THE ENDOPLASMIC RETICULUM$196,018
R01 · FY2001 · GM
PROTEIN QUALITY CONTROL IN THE ENDOPLASMIC RETICULUM$190,404
R01 · FY2000 · GM